![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, January 04, 2024 5:06:02 PM
Thank you very much. I don't know if you have HGEN shares, but I hope you have been following and decided to invest here. I further hope you have seen the latest posts, indicating that our CEO appears on his way to becoming our Debtor in Possession.
A Ch 11 bankruptcy was in the script before Kalobios became Humanigen, and a recall of our loaned shares was executed in that time frame, causing a huge short squeeze. I expect to see the same thing repeated, and I think the company could be holding 110M of the 119M shares in our OS. The float could be 192% of our OS.
I hope that bidding has been suppressed due to our lack of regulatory approval. Once Durrant wins the bid, I expect to see news regarding regulatory approvals for CMML and covid. I also think lenz will be used as a vaccine adjuvant for non-mRNA vaccines. This will allow the prophylaxis use of lenz, as well as the therapeutic use.
It was great to hear from you!
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM